Hepatopulmonary syndrome epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
<br /> | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence/prevalence of | *The incidence/prevalence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals worldwide. | ||
*In [year], the incidence/prevalence of | *In [year], the incidence/prevalence of hepatopulmonary syndrome was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
===Prevalence=== | ===Prevalence=== | ||
*The incidence/prevalence of | *The incidence/prevalence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals worldwide. | ||
*In [year], the incidence/prevalence of | *In [year], the incidence/prevalence of hepatopulmonary syndrome was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | *The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
*In [year], the incidence of | *In [year], the incidence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. | ||
*The case-fatality rate/mortality rate of | *The case-fatality rate/mortality rate of hepatopulmonary syndrome is approximately [number range]. | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop | *Patients of all age groups may develop hepatopulmonary syndrome. | ||
*The incidence of | *The incidence of hepatopulmonary syndrome increases with age; the median age at diagnosis is [#] years. | ||
* | *hepatopulmonary syndrome commonly affects individuals younger than/older than [number of years] years of age. | ||
*[Chronic disease name] is usually first diagnosed among [age group]. | *[Chronic disease name] is usually first diagnosed among [age group]. | ||
*[Acute disease name] commonly affects [age group]. | *[Acute disease name] commonly affects [age group]. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to hepatopulmonary syndrome. | ||
* | *hepatopulmonary syndrome usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop hepatopulmonary syndrome. | ||
===Gender=== | ===Gender=== | ||
* | *hepatopulmonary syndrome affects men and women equally. | ||
*[Gender 1] are more commonly affected by | *[Gender 1] are more commonly affected by hepatopulmonary syndrome than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. | ||
===Region=== | ===Region=== | ||
*The majority of | *The majority of hepatopulmonary syndrome cases are reported in [geographical region]. | ||
* | *hepatopulmonary syndrome is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | ||
===Developed Countries=== | ===Developed Countries=== |
Revision as of 20:48, 10 July 2019
Hepatopulmonary syndrome Microchapters |
Differentiating Hepatopulmonary syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatopulmonary syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Hepatopulmonary syndrome epidemiology and demographics |
FDA on Hepatopulmonary syndrome epidemiology and demographics |
CDC on Hepatopulmonary syndrome epidemiology and demographics |
Hepatopulmonary syndrome epidemiology and demographics in the news |
Blogs on Hepatopulmonary syndrome epidemiology and demographics |
Risk calculators and risk factors for Hepatopulmonary syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of hepatopulmonary syndrome was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of hepatopulmonary syndrome was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of hepatopulmonary syndrome is approximately [number range].
Age
- Patients of all age groups may develop hepatopulmonary syndrome.
- The incidence of hepatopulmonary syndrome increases with age; the median age at diagnosis is [#] years.
- hepatopulmonary syndrome commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to hepatopulmonary syndrome.
- hepatopulmonary syndrome usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop hepatopulmonary syndrome.
Gender
- hepatopulmonary syndrome affects men and women equally.
- [Gender 1] are more commonly affected by hepatopulmonary syndrome than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of hepatopulmonary syndrome cases are reported in [geographical region].
- hepatopulmonary syndrome is a common/rare disease that tends to affect [patient population 1] and [patient population 2].